<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>167(1)</volume><submitter>Battista F</submitter><funding>Università degli Studi di Firenze</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>For drug-resistant mesial temporal lobe epilepsy (MTLE), surgery is recommended. There is no evidence of a seizure outcome advantage of temporal lobectomy over other strategies despite the high risks of this surgical procedure.&lt;h4>Methods&lt;/h4>We describe a Temporal Resection guided by intraoperative stereo-electroencephalography (iSEEG) and the &lt;sup>18&lt;/sup>FluoroDeoxyGlucose PET (&lt;sup>18&lt;/sup>FDG PET) (iSP-TR) to treat lesional MTLE. We avoided functional cortical areas using navigated Transcranial Magnetic Stimulation (nTMS).&lt;h4>Conclusion&lt;/h4>iSP-TR allows for a spare brain parenchyma compared to temporal lobectomy without compromising seizure outcomes.</pubmed_abstract><journal>Acta neurochirurgica</journal><pagination>82</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11922984</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The intraoperative SEEG and &amp;lt;sup&amp;gt;18&amp;lt;/sup&amp;gt;FDG-PET tailored temporal lobe resection (iSP-TR) for the tissue-spearing surgical treatment of drug-resistant mesial temporal lobe epilepsy: how we do it.</pubmed_title><pmcid>PMC11922984</pmcid><pubmed_authors>Battista F</pubmed_authors><pubmed_authors>Grippo A</pubmed_authors><pubmed_authors>Della Puppa A</pubmed_authors><pubmed_authors>Carrai R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The intraoperative SEEG and &amp;lt;sup&amp;gt;18&amp;lt;/sup&amp;gt;FDG-PET tailored temporal lobe resection (iSP-TR) for the tissue-spearing surgical treatment of drug-resistant mesial temporal lobe epilepsy: how we do it.</name><description>&lt;h4>Background&lt;/h4>For drug-resistant mesial temporal lobe epilepsy (MTLE), surgery is recommended. There is no evidence of a seizure outcome advantage of temporal lobectomy over other strategies despite the high risks of this surgical procedure.&lt;h4>Methods&lt;/h4>We describe a Temporal Resection guided by intraoperative stereo-electroencephalography (iSEEG) and the &lt;sup>18&lt;/sup>FluoroDeoxyGlucose PET (&lt;sup>18&lt;/sup>FDG PET) (iSP-TR) to treat lesional MTLE. We avoided functional cortical areas using navigated Transcranial Magnetic Stimulation (nTMS).&lt;h4>Conclusion&lt;/h4>iSP-TR allows for a spare brain parenchyma compared to temporal lobectomy without compromising seizure outcomes.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-18T12:50:07.411Z</modification><creation>2025-04-06T22:12:56.895Z</creation></dates><accession>S-EPMC11922984</accession><cross_references><pubmed>40106065</pubmed><doi>10.1007/s00701-025-06491-x</doi></cross_references></HashMap>